The Effects of Serum Homocysteine on the Restenosis after Percutaneous Coronary Intervention

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Korean Circulation Journal

• Publication date

  2001-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4070/KCJ.2001.31.6.560
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Homocysteine as a Risk Factor for Restenosis after Coronary Angioplasty

  2000cited by this paper
• Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: a prospective study.

  2000cited by this paper
• [Plasma homocysteine is not a predictive factor of restenosis after coronary angioplasty].

  1999cited by this paper
• Plasma Homocysteine, Folate and Vitamin B12 Concentrations in Coronary Artery Disease

  1998cited by this paper
• Serum Total Homocysteine as a Risk Factor for Patients with Coronary Artery Disease

  1998cited by this paper
• Plasma Homocysteine and Risk of Myocardial Infarction in Young Age:Relation with Vitamine B6, B12, and Folate

  1998cited by this paper
• Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation.

  1997cited by this paper
• Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells.

  1996cited by this paper
• Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty

  1996cited by this paper
• A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

  1995cited by this paper
• Histomorphometric and biochemical correlates of arterial procollagen gene expression during vascular repair after experimental angioplasty.

  1995cited by this paper
• Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty.

  1995cited by this paper
• A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

  1995cited by this paper
• A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.

  1994cited by this paper
• Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.

  1994cited by this paper
• Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients.

  1993cited by this paper
• Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease.

  1992cited by this paper
• A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.

  1992cited by this paper
• Serum lipids and lipoproteins in relation to restenosis after coronary angioplasty.

  1991cited by this paper
• Hyperhomocysteinemia: an independent risk factor for vascular disease.

  1991cited by this paper
• The severity of coronary atherosclerosis at sites of plaque rupture with occlusive thrombosis.

  1991cited by this paper
• The spectrum of diseases of small coronary arteries and their physiologic consequences.

  1990cited by this paper
• Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells.

  1990cited by this paper
• Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.

  1989cited by this paper
• Angiographic morphology of coronary artery stenoses in prolonged rest angina: evidence of intracoronary thrombosis.

  1989cited by this paper
• Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry.

  1988cited by this paper
• Folic acid--an innocuous means to reduce plasma homocysteine.

  1988cited by this paper
• Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency.

  1988cited by this paper
• Homocysteinemia due to folate deficiency.

  1987cited by this paper
• Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.

  1986cited by this paper
• Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease.

  1985cited by this paper
• Angiographie morphology and the pathogenesis of unstable angina pectoris

  1985cited by this paper
• Angiographic morphology and the pathogenesis of unstable angina pectoris.

  1985cited by this paper
• Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis.

  1976cited by this paper
• Homocystinemia. Vascular injury and arterial thrombosis.

  1974cited by this paper
• Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.

  1969influential reference
• Activation of Hageman Factor by L-Homocystine

  1968cited by this paper

• Association of Waist Circumference with Risk Factors for Coronary Artery Diseases in Women Patients with Chest Pain

  2013cites this paper
• 흉통을 호소하는 여성 환자에서 허리둘레와 관상동맥질환 위험인자간의 관계에 관한 조사연구

  2013cites this paper
• Predictive Factors after Percutaneous Coronary Intervention in Young Patients with Acute Myocardial Infarction

  2007cites this paper